Payment overview · 2025
General Payments
$35.96
1 reported records · 1 companies
Healthcare provider profile · identity verified
Ross E Glider, DO
Allopathic & Osteopathic Physicians|Internal Medicine · TAMPA, FL · NPI 1457342768
Verified facts
What the public records show
CMS Open Payments records show Ross E Glider, DO received $35.96 in general payments during 2025 across 1 reported records.
Cipher Pharmaceuticals US LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Cipher Pharmaceuticals US LLC | Unresolved — no canonical attribution shown | $35.96 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $35.96 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Natroba Normalized: natroba |
Drug | Cipher Pharmaceuticals US LLC | $35.96 | 1 | 2025 |
Source payment records
|
|||||
| Spinosad Normalized: spinosad |
Drug | Cipher Pharmaceuticals US LLC | $35.96 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 275 | 41 |
| Levothyroxine Sodium | Levothyroxine Sodium | 271 | 28 |
| Gabapentin | Gabapentin | 221 | 29 |
| Famotidine | Famotidine | 215 | 26 |
| Trazodone Hcl | Trazodone Hcl | 206 | 29 |
| Amlodipine Besylate | Amlodipine Besylate | 201 | 27 |
| Eliquis | Apixaban | 186 | 18 |
| Losartan Potassium | Losartan Potassium | 161 | 20 |
| Potassium Chloride | Potassium Chloride | 161 | 19 |
| Furosemide | Furosemide | 159 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 158 | 18 |
| Metoprolol Tartrate | Metoprolol Tartrate | 147 | 21 |
| Pantoprazole Sodium | Pantoprazole Sodium | 137 | 23 |
| Buspirone Hcl | Buspirone Hcl | 132 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 125 | 15 |
| Lisinopril | Lisinopril | 115 | 18 |
| Metformin Hcl | Metformin Hcl | 115 | 16 |
| Tamsulosin Hcl | Tamsulosin Hcl | 104 | 12 |
| Omeprazole | Omeprazole | 100 | 16 |
| Meloxicam | Meloxicam | 99 | 13 |
| Sertraline Hcl | Sertraline Hcl | 92 | 14 |
| Clopidogrel | Clopidogrel Bisulfate | 88 | 11 |
| Risperidone | Risperidone | 88 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 81 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 79 | 33 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 78 | 11 |
| Alcohol Swabs | Alcohol Antiseptic Pads | 76 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 75 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 74 | suppressed |
| Januvia | Sitagliptin Phosphate | 73 | suppressed |
| Levetiracetam | Levetiracetam | 71 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 69 | 13 |
| Simvastatin | Simvastatin | 67 | suppressed |
| Lactulose | Lactulose | 66 | 20 |
| Mirtazapine | Mirtazapine | 66 | 11 |
| Latanoprost | Latanoprost | 65 | 11 |
| Nystatin | Nystatin | 63 | 17 |
| Cefdinir | Cefdinir | 61 | 33 |
| Tramadol Hcl | Tramadol Hcl | 61 | 11 |
| Divalproex Sodium | Divalproex Sodium | 60 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 58 | suppressed |
| Spironolactone | Spironolactone | 57 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 56 | 18 |
| Baclofen | Baclofen | 56 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 56 | suppressed |
| Azithromycin | Azithromycin | 55 | 37 |
| Loperamide | Loperamide Hcl | 54 | 35 |
| Bumetanide | Bumetanide | 53 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 51 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 50 | suppressed |
| Lamotrigine | Lamotrigine | 49 | suppressed |
| Clonazepam | Clonazepam | 48 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 48 | suppressed |
| Bupropion Xl | Bupropion Hcl | 47 | suppressed |
| Memantine Hcl | Memantine Hcl | 44 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 43 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 42 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 42 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 41 | 25 |
| Breo Ellipta | Fluticasone/Vilanterol | 40 | suppressed |
| Hydrocortisone | Hydrocortisone | 39 | 21 |
| Citalopram Hbr | Citalopram Hydrobromide | 38 | suppressed |
| Carvedilol | Carvedilol | 37 | suppressed |
| Topiramate | Topiramate | 37 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 36 | suppressed |
| Nifedipine Er | Nifedipine | 34 | suppressed |
| Finasteride | Finasteride | 33 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 32 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 32 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 31 | suppressed |
| Alprazolam | Alprazolam | 30 | suppressed |
| Glipizide | Glipizide | 29 | suppressed |
| Paliperidone Er | Paliperidone | 28 | suppressed |
| Methylprednisolone | Methylprednisolone | 26 | 19 |
| Alendronate Sodium | Alendronate Sodium | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 25 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 13 |
| Glimepiride | Glimepiride | 24 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 24 | suppressed |
| Levemir Flexpen | Insulin Detemir | 23 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 23 | suppressed |
| Restasis | Cyclosporine | 22 | suppressed |
| Lorazepam | Lorazepam | 21 | suppressed |
| Olanzapine | Olanzapine | 21 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 19 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 19 | suppressed |
| Rhopressa | Netarsudil Mesylate | 19 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 19 | suppressed |
| Torsemide | Torsemide | 19 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 18 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 18 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Linzess | Linaclotide | 18 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | 11 |
| Primidone | Primidone | 16 | suppressed |
| Atenolol | Atenolol | 15 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 15 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Permethrin | Permethrin | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Amantadine | Amantadine Hcl | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Methotrexate | Methotrexate Sodium | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 14 | suppressed |
| Vascepa | Icosapent Ethyl | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Butalbital-Aspirin-Caffeine | Butalbital/Aspirin/Caffeine | 13 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Valproic Acid | Valproic Acid | 13 | suppressed |
| Allopurinol | Allopurinol | 12 | suppressed |
| Aripiprazole | Aripiprazole | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Mesalamine Er | Mesalamine | 12 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 12 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 12 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Sure Comfort Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 11 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Fluorometholone | Fluorometholone | 11 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 11 | suppressed |
| Movantik | Naloxegol Oxalate | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Trulicity | Dulaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $35.96 · 1 records | Cipher Pharmaceuticals US LLC | Natroba, Spinosad | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error